Pharmacolog i Uppsala AB
Mistreatments with intravenous drugs cause serious damages and sometimes deaths to patients. The yearly cost for mistreatments with drugs in the USA is about 10 billion USD including death of 200 patients per day.
Pharmacolog i Uppsala AB is a Medical Device company based in Uppsala, Sweden. The company specializes in providing quality assurance solutions for safe administration of medications. The company was established in 2007 by Hans Dahlin and Kjell Westerlund.
The company’s lead product, DrugLog, focuses on the quality control in drug administration in the clinical setting.
The company is owned by several national and international small companies and private equity investors. The CEO of the company is Hans Dahlin, who has clinical and company leadership background in mainly the Oncology field since more than 30 years.
The patented core technology is based on absorption spectroscopy in the UV spectral range.
A built in computer allows connection to local networks for integrating with existing patient, treatment, drug prescription records, and other related databases, to ensure that the right drug with right concentration is given to the right patient at the right occasion.
DrugLog has been tested and verified at hospital pharmacies preparing chemotherapy drugs and at Oncology Departments in Sweden. The first international reference site for scientific clinical tests and evaluation of DrugLog is established with the pharmacy at the Hôpitaux Universitaires Genève.